Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
- Sprache
-
Englisch
- Identifier
-
1179448928
- Beteiligte Personen und Organisationen
-
Bakhtiar, Shahrzad
Woelke, Sandra
Hünecke, Sabine
Kieslich, Matthias
Taylor, Alexander Malcolm
Schubert, Ralf
Zielen, Stefan
Bader, Peter
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:56 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bakhtiar, Shahrzad
- Woelke, Sandra
- Hünecke, Sabine
- Kieslich, Matthias
- Taylor, Alexander Malcolm
- Schubert, Ralf
- Zielen, Stefan
- Bader, Peter
Ähnliche Objekte (12)
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation
Prostaglandin l2 and Caveolin-1 in allogeneic hematopoietic stem cell transplantation
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Monitoring of measurable residual disease using circulating DNA after allogeneic hematopoietic cell transplantation
Mocravimod, a selective S1PR modulator in allogeneic hematopoietic stem cell transplantation for malignancy
Strategies and Clinical Implications of Chimerism Diagnostics after Allogeneic Hematopoietic Stem Cell Transplantation
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation
Prostaglandin l2 and Caveolin-1 in allogeneic hematopoietic stem cell transplantation
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Monitoring of measurable residual disease using circulating DNA after allogeneic hematopoietic cell transplantation
Mocravimod, a selective S1PR modulator in allogeneic hematopoietic stem cell transplantation for malignancy
Strategies and Clinical Implications of Chimerism Diagnostics after Allogeneic Hematopoietic Stem Cell Transplantation
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation
Prostaglandin l2 and Caveolin-1 in allogeneic hematopoietic stem cell transplantation
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Monitoring of measurable residual disease using circulating DNA after allogeneic hematopoietic cell transplantation
Mocravimod, a selective S1PR modulator in allogeneic hematopoietic stem cell transplantation for malignancy